CRYPTOSPORIDIUM PARVUM - ANVISA Registration 80464810924
Access comprehensive regulatory information for CRYPTOSPORIDIUM PARVUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810924 and manufactured by HYSEN BIOTECH.LNC. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATรRIOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, REMEL EUROPE LIMITED, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80464810924
25351083718202531
09377976000152
Company Information
Dates and Status
Jun 30, 2025
VIGENTE
09/18/2025 19:00:01
R-BIOPHARM AGโข Germany
REMEL EUROPE LIMITEDโข United Kingdom
EPITOPE DIAGNOSTICSโข United States of America
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDAโข Brazil
TECHLAB, INCโข United States of America
CRYPTOSPORIDIUM PARVUM
RIDASCREENยฎ Cryptosporidium
R-BIOPHARM AG
82890930010
Apr 28, 2025
CRYPTOSPORIDIUM PARVUM
FASTLINE CRYPTOSPORIDIUM Ag
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA
80105220131
May 02, 2023
CRYPTOSPORIDIUM PARVUM
CRYPTOSPORIDIUM II
TECHLAB, INC
80001590006
Oct 20, 2022
CRYPTOSPORIDIUM PARVUM
RIDASCREEN CRYPTOSPORIDIUM
R-BIOPHARM AG
80826840116
Oct 21, 2019
CRYPTOSPORIDIUM PARVUM
FAMรLIA RIDA QUICK CRYPTOSPORIDIUM CASSETE/TIRAS
R-BIOPHARM AG
80826840127
Oct 21, 2019

